tiprankstipranks
Trending News
More News >
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
US Market

Rani Therapeutics Holdings (RANI) Income Statement

Compare
1,518 Followers

Rani Therapeutics Holdings Income Statement

Last quarter (Q3 2025), Rani Therapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rani Therapeutics Holdings's net income was $-5.41M. See Rani Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.03M$ 0.00$ 0.00$ 2.72M$ 462.00K
Gross Profit
$ 1.03M$ -822.00K$ 0.00$ 2.72M$ 462.00K
Operating Expenses
$ 54.34M$ 65.28M$ 63.45M$ 54.32M$ 17.01M
Depreciation and Amortization
$ 1.03M$ 822.00K$ 548.00K$ 497.00K$ 589.00K
EBITDA
$ -50.52M$ -65.28M$ -61.66M$ -52.08M$ -15.96M
Operating Income
$ -53.31M$ -66.10M$ -63.45M$ -51.60M$ -16.54M
Other Income/Expenses
$ 23.30M$ -1.78M$ 177.00K$ -1.45M$ -124.00K
Pretax Income
$ -30.02M$ -67.88M$ -63.27M$ -53.05M$ -16.67M
Net Income
$ -30.02M$ -33.97M$ -30.59M$ -8.33M$ -16.70M
Per Share Metrics
Basic EPS
$ -1.05$ -1.33$ -1.28$ -0.42$ -0.85
Diluted EPS
$ -1.05$ -1.33$ -1.28$ -0.42$ -0.85
Weighted Average Shares Outstanding
28.48M 25.50M 23.82M 19.53M 18.74M
Weighted Average Shares Outstanding (Diluted)
28.48M 25.50M 23.82M 19.53M 18.74M
Currency in USD

Rani Therapeutics Holdings Earnings and Revenue History